Paul Kaijen

Technician
Department of Molecular Hematology, Sanquin Research, Amsterdam, The Netherlands
Amsterdam, Noord-Holland, Netherlands

Presentation(s):

• OC 44.3 - Exploring red blood cells as a novel tolerogenic approach for factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II

  Monday, June 26, 2023
  15:15 – 15:30 ET